KD Logo

Abbott Laboratories [ABT] Stock sold by Insider Earnhardt Lisa D for $2.43 million

In a filing, Abbott Laboratories revealed its EXECUTIVE VICE PRESIDENT Earnhardt Lisa D unloaded Company’s shares for reported $2.43 million on May 07 ’24. In the deal valued at $106.25 per share,22,852 shares were sold. As a result of this transaction, Earnhardt Lisa D now holds 61,462 shares worth roughly $6.44 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Then, Salvadori Daniel Gesua Sive sold 963 shares, generating $114,116 in total proceeds. Upon selling the shares at $118.50, the EXECUTIVE VICE PRESIDENT now owns 125,697 shares.

Before that, ALLEN HUBERT L sold 853 shares. Abbott Laboratories shares valued at $101,080 were divested by the EXECUTIVE VICE PRESIDENT at a price of $118.50 per share. As a result of the transaction, ALLEN HUBERT L now holds 184,806 shares, worth roughly $19.36 million.

Wolfe Research upgraded its Abbott Laboratories [ABT] rating to a Peer perform from a an Underperform in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in late May from “an Overweight” to “an Equal-weight”. Wolfe Research also remained covering ABT and reiterated its “an Underperform” recommendation on April 20, 2023. UBS maintained its rating on April 20, 2023. It rated ABT as “a Buy”.

Price Performance Review of ABT

On Monday, Abbott Laboratories [NYSE:ABT] saw its stock jump 0.03% to $104.77. Over the last five days, the stock has lost -0.82%. Abbott Laboratories shares have fallen nearly -4.82% since the year began. Nevertheless, the stocks have fallen -4.80% over the past one year. While a 52-week high of $121.64 was reached on 03/08/24, a 52-week low of $89.67 was recorded on 04/17/24. SMA at 50 days reached $110.98, while 200 days put it at $106.42. A total of 5.42 million shares were traded, compared to the trading of 7.35 million shares in the previous session.

Levels Of Support And Resistance For ABT Stock

The 24-hour chart illustrates a support level at 104.28, which if violated will result in even more drops to 103.79. On the upside, there is a resistance level at 105.38. A further resistance level may holdings at 105.99. The Relative Strength Index (RSI) on the 14-day chart is 34.12, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.24, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.47%. Stochastics %K at 11.42% indicates the stock is a buying.

The most recent change occurred on April 20, 2023 when Raymond James resumed its ‘”an Outperform”‘ rating for the stock and retained the price target to $123.

Most Popular